25 results
6-K
EX-10.1
PRQR
ProQR Therapeutics N.V
8 Dec 23
ProQR Therapeutics Announces Transaction Completed for Théa to Acquire Sepofarsen and Ultevursen Ophthalmic Assets
7:37am
6-K
EX-10.1
PRQR
ProQR Therapeutics N.V
23 Dec 22
Current report (foreign)
7:10am
6-K
EX-10.2
PRQR
ProQR Therapeutics N.V
23 Dec 22
Current report (foreign)
7:10am
6-K
EX-10.1
PRQR
ProQR Therapeutics N.V
30 Dec 21
ProQR Announces Amendment to Convertible Debt Financing Agreement with Pontifax Ventures and Kreos Capital
7:19am
6-K
EX-10.2
PRQR
ProQR Therapeutics N.V
30 Dec 21
ProQR Announces Amendment to Convertible Debt Financing Agreement with Pontifax Ventures and Kreos Capital
7:19am
6-K
EX-10.3
lm9912h nb
30 Dec 21
ProQR Announces Amendment to Convertible Debt Financing Agreement with Pontifax Ventures and Kreos Capital
7:19am
6-K
EX-10.4
gzv5occ95qlr3 nsa
30 Dec 21
ProQR Announces Amendment to Convertible Debt Financing Agreement with Pontifax Ventures and Kreos Capital
7:19am
6-K
EX-10.1
jbbnnv3w
8 Sep 21
ProQR Announces Axiomer® RNA Editing Licensing and Research Collaboration with Lilly
4:10pm
6-K
EX-10.2
nsz18mfp8 qeb1w
8 Sep 21
ProQR Announces Axiomer® RNA Editing Licensing and Research Collaboration with Lilly
4:10pm
6-K
EX-10.1
hdsqfyzc7h8owf6mb929
6 Aug 20
Current report (foreign)
4:30pm
6-K
EX-10.3
xmvhga8
14 Jul 20
ProQR Announces $30 Million Strategic Convertible Debt Financing Agreement with Pontifax Ventures
5:21pm
6-K
EX-10.2
l6mod0 be
14 Jul 20
ProQR Announces $30 Million Strategic Convertible Debt Financing Agreement with Pontifax Ventures
5:21pm
6-K
EX-10.1
yoay3
14 Jul 20
ProQR Announces $30 Million Strategic Convertible Debt Financing Agreement with Pontifax Ventures
5:21pm
6-K
EX-10.1
177haumqx5bdrb
9 Oct 14
Current report (foreign)
12:00am
F-1/A
EX-10.8
ruwklvg8 3cog7he3yt
16 Sep 14
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-10.5
uon8r oxav9u5wj
16 Sep 14
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-10.2
fjq110a7cdd79yl bs5a
8 Sep 14
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-10.3
992m9 8g0z
8 Sep 14
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-10.10
2tf86r
8 Sep 14
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-10.4
hpm 7raqc2xgz
8 Sep 14
Registration statement (foreign) (amended)
12:00am